Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...

The FDA approved a wearable tumor-treating fields (TTFields) device (Optune Lua) for concurrent use with a PD-1/PD-L1 ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

If cancer has spread to the bone, the most common symptom is bone pain, which can be a dull ache or stabbing pain. The pain ...

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

Men with prostate cancer diagnosed at an early stage may be able to slow the progression of their disease by adopting a ...

Behind breast cancer, prostate cancer is the second most common cancer in the United States. Since its opening in 2012, the ...

TULSA-PRO is an improvement on long-time prostate cancer treatment that called for radiation or the removal of the entire ...

Prostate cancer is the second-leading cause of cancer death in the United States. Not everyone experiences symptoms, which is ...

In a study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific ...

New research provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance -- a ...

At the moment, patients must request a blood test from their doctor, but Prostate Cancer UK is calling for change.